New technology to facilitate testing of viral load of HIV
New technology to facilitate testing of viral load of HIV.New technology will facilitate viral load testing, making results available in minutes, and can also be used by non-laboratory trained personnel in facilities that are not conventional laboratory environments.
Viral load tests measure the number of copies of HIV in a patient’s blood, which determines the type of antiretroviral therapy that will be effective.
With the available technology, it took several weeks for patients to obtain the results of their viral load, since the tests would be performed in the facilities of the central laboratory, which required the transport of blood samples from different health facilities to the laboratory. central. , before the results are returned to patients.
“In some circumstances, everything is fine (wait longer), but sometimes you may want to get the results on the same day, for example, for a woman who is going to give birth, we need to know if her viral load is suppressed or not.
Because it determines the likelihood of passing HIV to the baby, “said Dr. Kuku Appiah, Director of Medical and Scientific Affairs. Abbot Rapid Diagnostics, a branch of Abbott Laboratories, an American healthcare company that advocates for technology.
Dr. Appiah was in Rwanda on July 4th and presented the solution to health sector actors.
In an interview with the Sunday Times, he said the new technology miniaturized the viral load laboratory, making it easy to run tests in smaller unfinished labs and untrained staff. in laboratory and results It can be obtained in 70 minutes.
New technology to facilitate testing of viral load of HIV or more
“It provides very accurate results comparable to those of a laboratory,” he said.
“But the difference is that it can be done in a rural clinic and by someone who is not trained in the laboratory.”
He emphasized the ease of use of the technology, since user interaction is not necessary, laboratory reagents are not used and air conditioning is not required.
Nicknamed “m-PIMA”, the technology has been prequalified by the World Health Organization (WHO).
Dr. Appiah said some of his rapid diagnostic solutions are already being used in Rwanda for early diagnosis in babies born to HIV-positive women.
According to the United Nations Program on HIV / AIDS, the viral load test is the “gold standard” for HIV treatment surveillance. The tests provide an accurate way to determine if antiretroviral therapy can suppress virus replication.
Obtaining viral suppression protects the body’s immune system, helps people living with HIV to stay healthy, and prevents transmission of HIV to others.
In 2013, WHO recommended the viral load test as a preferred surveillance tool to diagnose and confirm the failure of antiretroviral therapy.
WHO recommends monitoring viral load 6 and 12 months after starting antiretroviral therapy, then annually for stable people.